Market Signal Briefing

AI-Identified Memorabilia Acquired This Weekend Expected to Support Long-Term Funding for Technology Development

MESA, ARIZONA / ACCESS Newswire / December 16, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) is thrilled to announce the powerful collaboration between its subsidiaries, Real Game Used (RGU) and Infinite Auctions. Utilizing RGU's patent-pending AI technology, Infinite Auctions has successfully identified and acquired rare, photo-matched memorabiliasignificantly more valuable than their purchase price.

AI-Driven Photo-Match Discoveries and Synergy in Action

This collaboration highlights the synergy between RGU and Infinite Auctions. RGU's AI technology has enabled the discovery of these high-value items through precise photo-matching, and Infinite Auctions has authenticated and secured these pieces. These items are expected to be sold at a substantial premium, fueling exponential revenue growth and strengthening Medical Care Technologies' financial foundation.

"As we leverage RGU's AI to identify these valuable photo-matched pieces, we're witnessing firsthand the exponential potential that comes from combining RGU's innovative technology with Infinite Auctions' market expertise," said Marshall Perkins, CEO of MDCE. "This synergy not only bolsters our financial strength but also ensures that we have the resources to drive forward our ambitious AI app development plans."

Strengthening the Future of App Development and Marketing

The anticipated revenue from these sales will provide a solid financial foundation for MDCE's upcoming AI applications, ensuring continued innovation in both consumer and healthcare verticals.

About Us

Medical Care Technologies Inc. (OTC Pink:MDCE) is a forward-looking company dedicated to developing innovative AI-driven applications. Our subsidiaries, including Infinite Auctions and Real Game Used, work in synergy to deliver cutting-edge solutions in sports memorabilia and healthcare technology.

Safe Harbor Statement

This press release contains forward-looking statements that involve risks and uncertainties. Such statements are based on current expectations and assumptions and are subject to various risks and uncertainties that could cause actual results to differ materially from those anticipated. The company undertakes no obligation to update any forward-looking statements.

Source: Medical Care Technologies Inc. (OTC Pink:MDCE)

For more information, visit www.mdcestock.com.

Contact:

Investor Relations
Medical Care Technologies Inc.
[email protected]
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc.

Legendary publication's annual best-of list celebrates the automotive industry's top trucks and SUVs
Palisade's all-new, next-generation hybrid system pairs a 2.5-liter turbocharged four-cylinder and two electric motors to deliver up to 329 horsepower and up to 619 miles of driving range
New available convenience technologies include First- and second-row Relaxation seating, Digital Key 2, 100-watt capable USB-C ports, EV-like Stay Mode, and factory-installed tow hitch
New available safety technologies: Built-in dual-camera Dash Cam, ten airbags, third-row seatbelt pre-tensioners and load limiters
, /PRNewswire/ -- Today, Hyundai's all-new Palisade Hybrid has been named to Car and Driver's prestigious 10Best Trucks and SUVs list for 2026. Car and Driver's annual 10Best list 10Best recognizes the industry's best trucks and SUVs for the year. This new 10Best honor adds to an already lengthy list of awards and accolades won by Hyundai SUVs. 2026 marks the fourth-consecutive year that a Hyundai model has been honored with a position on the list.

Hyundai Palisade Hybrid SUV photographed in California City, Calif. on Mar. 4, 2025.

Hyundai Palisade Hybrid SUV photographed in California City, Calif. on Mar. 4, 2025.

Hyundai Palisade SUV interior photographed in California City, Calif. on Mar. 4, 2025.

"A potent powertrain and a top-tier interior put the new Hyundai Palisade Hybrid on the board in its debut year," said Car and Driver Editor-in-Chief Tony Quiroga.

"For us, the Palisade Hybrid making Car and Driver's 10Best Trucks and SUVs list is more than a win; it's a marker of where the market is moving. Families want no-compromise capability, adult-ready third-row seating, and intuitive technology that makes daily life simpler," said Olabisi Boyle, senior vice president, product planning and mobility strategy, Hyundai Motor North America. "The team is designing for the full curve of customers, and that strategy enables resilience across all market environments, where consumer preferences and economic pressures rarely shift in sync. We are truly grateful for the inclusion on this list."

The Palisade's all-new design is bold yet refined, encapsulating a more-refined platform that delivers improved space for people and cargo. The newly available hybrid powertrain delivers increased power, fuel efficiency, and driving range, ensuring that Palisade is ready to meet the needs of more families than ever before. It's not just Palisade's additional space and rugged ability that impresses; its infotainment, convenience, and advanced safety-system upgrades ensure that this new model is more capable in every dimension.

Bold, premium SUV design

The new Palisade displays a commanding, premium aura thanks to design worthy of a flagship SUV. The front presents a distinctive vertical LED daytime running light graphic and a horizontal center positioning light signature, conveying a wider stance while highlighting the bold grille, with active airflow shutters integrated into the lower fascia for improved efficiency. A horizontal hood line couples with a more upright A-pillar for a strong side profile. Even with this bold, upright appearance, a remarkable 0.31 Cd has been achieved, one of the lowest in the segment.

From the side, proportions are larger overall, with a shorter front overhang (-1.6 in.), longer overall length (+2.5 in.) and wheelbase (+2.7 in.), and a lengthened rear cabin to yield a substantial, premium silhouette. Large alloy wheels – up to 21 inches -- generously fill the wheel openings, readily conveying the commanding, planted road presence befitting of a range-topping SUV. Bold, forward-raked D-pillars, and larger, panoramic side glass flood Palisade's more spacious third row with light and improved visibility.

From the rear, a prominent, upper high-mounted wide stop lamp is visually balanced with a lower fascia element for ideal design harmony. The greenhouse's more upright tumblehome and higher shoulder lines create a stronger on-road presence while enhancing interior spaciousness. The bold D-pillar form connects seamlessly with the vertical rear lamp signature and integrated roof rails.

Intuitive interior design elements

The new Palisade is larger in every key dimension: the body spans 2.5 inches longer and the wheelbase is 2.7 inches longer than the previous generation, allowing for easier passenger ingress and egress. Available in both seven- and eight-seat configurations, the expanded interior employs a horizontal dashboard layout with soft-touch materials, sophisticated finishes, and a differentiated luxury ambience.

The center console is shaped to enhance seat roominess, enveloped by premium materials inspired by luxury home furnishings. The center console and armrest have not only been designed for comfort, but also to enhance ergonomic stability when reaching for vehicle controls. Palisade offers a double-door center stack with an open tray in the lower part of the console coupled with conveniently placed physical switchgear. A wireless charging pad with an integrated device-cooling fan is ideally located in the center console. The pad provides a generous 15 watts for fast device charging, making for the perfect companion to Palisade's standard wireless Apple CarPlay® and Android Auto™ integration. An available Bose® 14-speaker surround audio system ties the entire premium cabin experience together, enveloping all three rows in rich, lifelike sound. In addition, a panoramic, curved digital instrument cluster and navigation system with dual 12.3-inch displays provides key information in easy view of the driver.

2026 Palisade now offers innovative Relaxation seats for front- and second-row passengers, providing generous additional degrees of recline and deployable upper-leg supports to help reduce fatigue during extended seating periods. The interior's design and capacious dimensions invite serenity and a sense of occasion. Eight-passenger seating is standard for family adventures. Available captain's chairs include one-touch second-row tilt-and-slide functionality for effortless operation, facilitating easy third-row access. For more convenience, the third-row seats are available with power-folding, sliding, and power-reclining mechanisms, along with heating. Second-row power-adjustable seats offer heating and ventilation for extra comfort. Available second- and third-row seat articulation functions can also be controlled from the driver's seat or cargo area for extra convenience whenever picking up passengers and their cargo. Cup holders and 100-watt-capable USB-C ports are readily accessible in each row, ensuring every occupant and every device remain juiced up for the entire journey.

Advanced technology looks out for you and your family's safety and wellbeing at every turn

In addition to Hyundai's SmartSense suite of active- and passive safety features, the 2026 Palisade protects families in a myriad of unique ways – while driving, or even when you're parked. In a first for Hyundai, the built-in, two-camera Dash Cam can provide continuous recording while driving. It can also work with various vehicle sensors to automatically record nearby movements while parked.

The 2026 Palisade supports the latest version of Hyundai Digital Key 2.0 Premium2 which allows owners to leave their key fob at home and use a supported smartphone or smartwatch to lock, unlock, and start their vehicle. Palisade also offers Wi-Fi hotspot3 capability with Alexa Built-in Voice Assistant capability.14 Vehicles with cellular connectivity will be able to provide a hotspot that allows others to browse the internet, stream videos or music and more – just like at home.

Speaking of connectivity, the new Palisade comes standard with wireless Over-The-Air (OTA)4 update capability. This technology ensures that the vehicle's major controls remain up to date, also clearing the way for software additions and new features to be added remotely. After it leaves the factory, the new Palisade is only going to get smarter.

New, powerful, and efficient hybrid powertrain

The 2026 Palisade offers a new hybrid powertrain for the first time. It features a 2.5-liter turbocharged in-line four-cylinder engine putting out up to 258 horsepower. Two electric motors mounted in the six-speed automatic transmission's case create a combined total system output of up to 329 horsepower and up to 339 pound-feet of torque. Palisade HEV's high-efficiency powertrain offers an EPA-estimated 35 mpg on the highway for the FWD model, yielding an internally targeted range of up to 619 miles1. The hybrid powertrain also offers an estimated 4,000 lbs. of maximum towing capacity5, all of which combine for supreme driver confidence and flexibility out on the open road. Specific features have been added to the hybrid to provide a more EV-like ownership experience, including a new Stay Mode function that monitors the battery system when parked to allow for extended use of the infotainment and HVAC functions.

The 2026 Palisade also offers a gasoline-only 3.5-liter V6 that delivers an estimated 287 horsepower and 260 pound-feet of torque, with towing capacity of up to 5,000 pounds5.

New safety and driver convenience technologies

Hyundai knows today's SUV owners shouldn't have to compromise when it comes to protecting their passengers, so the 2026 Palisade delivers a full complement of SmartSense active safety technologies. The new model's generous suite of Advanced Driver Assist Systems (ADAS) includes many key features, including Forward Collision-Avoidance Assist6, Blind-Spot Collision Warning7, Safe Exit Assist8, Forward Attention Warning9, High Beam Assist, Navigation-Based Smart Cruise Control10, Lane Following Assist, Rear Cross-Traffic Collision-Avoidance Assist11, Parking Collision-Avoidance Assist-Reverse12, and Remote Smart Parking Assist13.

Hyundai Motor America

Hyundai Motor America offers U.S. consumers a technology-rich lineup of cars, SUVs, and electrified vehicles, while supporting Hyundai Motor Company's Progress for Humanity vision. Hyundai has significant operations in the U.S., including its North American headquarters in California, the Hyundai Motor Manufacturing Alabama assembly plant, the all-new Hyundai Motor Group Metaplant America, and several cutting-edge R&D facilities. These operations, combined with those of Hyundai's 850 independent dealers, contribute $20.1 billion annually and 190,000 jobs to the U.S. economy, according to a published economic impact report. For more information, visit www.hyundainews.com.

Hyundai Motor America on Twitter | YouTube | Facebook | Instagram | LinkedIn | TikTok

Footnotes

1                         Estimated driving range of 619 miles for 2026 Palisade Hybrid Blue SEL Premium based on a fully-charged battery. Estimated ranges for other trims vary. For comparison purposes only. Actual range will vary based on a number of factors, including vehicle options, driving conditions and habits, vehicle and battery's condition and outside temperature.

2                         Digital smartphone key requires a compatible smartphone and an appropriately equipped Hyundai vehicle. Not all smartphones are compatible. Hyundai vehicle must be equipped with smart key with push button start, wireless device charging, and Audio Video Navigation System 5.0 (or newer) or Display Audio 2.0. Tap to lock/unlock function works on front doors only. Requires MyHyundai with Bluelink app and active Bluelink account. Please visit www.MyHyundai.com for information on compatible devices. Features and specifications are subject to change. See your Owner's Manual for additional details and limitations.

3                         Wi-Fi Hotspot + Streaming is available on select 2026 and newer Hyundai models. Requires trial or paid data plan, active Hyundai Bluelink account and acceptance of Hyundai Motor America Connected Services Terms and Conditions. Coverage and service are not available in all areas. Cellular and GPS coverage is required. Streaming services are provided by third parties and subject to their fees, terms, and conditions. Wi-Fi Hotspot + Streaming trial begins on activation date and expires at the end of three months or after 3GB of data is used, whichever comes first. Paid data plan required upon end of Wi-Fi Hotspot + Streaming trial. Limit one trial per vehicle. Up to 5 devices can be supported using in-vehicle connectivity. Only use Wi-Fi and connected devices when safe to do so. See https://www.verizon.com/support/hyundai-connect-legal/ for terms and conditions.

4                         Over-the-Air (OTA) software updates are available and complimentary to original purchasers and lessees of new 2026 Palisade Bluelink-equipped Hyundai models ("Eligible Models"). Map and multimedia OTA updates are available and complimentary to original purchasers and lessees of Eligible Models for an initial three-year term, after which fees apply. Three-year term starts from new vehicle date of first use. OTA updates require an Eligible Model and an active Bluelink account subject to the Connected Services Terms and Conditions. Only use Bluelink features and corresponding devices when safe to do so. Cellular and GPS coverage is required. Features, specifications, and fees are subject to change.

Bluelink services rely on digital wireless telecommunications technology outside of Hyundai's control. Bluelink is dependent on 4G LTE cellular networks controlled and maintained by third-party wireless carriers. If and when these networks change and/or discontinue service, or their underlying technology required to support Bluelink becomes obsolete, then the connected services will not work and Hyundai will be forced to cancel impacted subscription services.

5                         Towing capacity varies by configuration. 4,000 lb. maximum towing capacity for 2026 Palisade Hybrid models and 5,000 lb. maximum towing capacity for Palisade ICE models. Requires installation of aftermarket towing equipment. See Owner's Manual for proper use and additional information.

6                         The Forward Collision-Avoidance Assist with Pedestrian Detection (FCA-Ped) is intended to be a supplement to safe driving practices. The system is not designed to detect certain stationary objects such as trees or poles and may not detect all vehicles or pedestrians under certain conditions. The system is a driver assistance system and is not a substitute for safe driving. The driver is responsible for being attentive and maintaining control of the vehicle and should not wait for the system's alerts before braking as there may not be sufficient time to brake safely. See Owner's Manual for further details and limitations.

7                         Blind-Spot Collision Warning (BCW) assists the driver by warning of other cars in the blind spot region. It senses the rear side territory of the vehicle when it is traveling over 20 mph. There are limitations to the function, range, detection, and clarity of the system. It will not detect all vehicles or objects in the blind spot. Its operation depends on the size, distance, angle and relative speed difference between your car and other cars. BCW may not operate if sensors are obscured in any way. Do not rely exclusively on BCW. BCW is a supplemental system and the driver must still be attentive and exercise caution when driving. It is important to always signal, look over your shoulder and through your mirrors before changing lanes. It is the driver's responsibility to be aware of the surroundings and ensure it is clear before changing lanes or directions. See Owner's Manual for further details and limitations.

8                         When the vehicle is parked, Safe Exit Assist (SEA) can alert the driver when a vehicle is approaching from behind. When Child Locks are active, SEA prevents initial disabling of the child safety locks if a vehicle approaching from behind is detected. SEA does not work in all situations and is not a substitute for driver or passenger attentiveness. Always be aware of your surroundings and attentive of approaching vehicles. See Owner's Manual for further details and limitations.

9                         Forward Attention Warning is only a warning to inform the driver of a potential lack of driver attention or drowsiness. It does not detect and provide an alert in every situation. It is the driver's responsibility to remain alert at all times. See Owner's Manual for further details and limitations.

10                       Navigation-based Smart Cruise Control (N-SCC) with Stop & Go and Curve Control can help automatically adjust vehicle speed when driving on highways by using road information from the navigation system. N-SCC only operates on main roads of select highways and does not operate at interchanges or junctions. N-SCC should not be used in poor weather, heavy or varying traffic, on winding or slippery roads, or if the navigation system is not working properly. N-SCC is a driver convenience feature and not a collision avoidance or warning device. Driver remains responsible for checking the speed limit and distance to the vehicle ahead, steering the vehicle and slowing or stopping the vehicle to avoid a collision. See Owner's Manual for further details and limitations.

11                        Rear Cross-Traffic Collision-Avoidance Assist (RCCA) can alert the driver of a potential collision by providing an audible warning and/or applying braking. RCCA is active when the vehicle is in reverse and operating at low speeds. Never rely exclusively on RCCA. RCCA cannot prevent all collisions and may not provide alerts or braking in all conditions. Always look over your shoulder and use your mirrors to confirm rear clearance. There are limitations to the function, detection, range, and clarity of the system. See Owner's Manual for further details and limitations.

12                       Parking Collision-Avoidance Assist – Reverse (PCA-R) can alert the driver of a potential hazard while reversing by providing an audible warning and/or applying braking. PCA-R is active when the vehicle is in reverse and operating at low speeds. Never rely exclusively on PCA-R. PCA-R cannot prevent all collisions and may not provide alerts or braking in all conditions. Always look over your shoulder and use your mirrors to confirm rear clearance. See Owner's Manual for feature details and limitations.

13                       Remote Smart Parking Assist (RSPA) can remotely help park the vehicle. However, several factors can impact RSPA performance. RSPA may not function correctly if one or more of the parking sensors is damaged, dirty, or covered or if weather conditions (heavy rain, snow, or fog) interfere with sensor operation. Always inspect the parking area with your own eyes. See Owner's Manual for further details and limitations.

14        Amazon, Alexa and all related marks are trademarks of Amazon.com, Inc. or its affiliates.

SOURCE Hyundai Motor America

'Big Short' investor Michael Burry sold GameStop weeks before it skyrocketed: 'I had no idea what was coming'

By

Theron Mohamed

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.

Michael Burry, the investor of "The Big Short" fame, revisited his GameStop bet on Substack.

Jim Spellman/WireImage

2025-12-16T14:30:47.070Z

Michael Burry replayed his GameStop bet in a Substack post on Monday.
The "Big Short" investor wrote that a "crappy business" became the "belle of the ball" in 2021.
Burry sold before the meme-stock boom as he was "blinded" by the risks and had seen little payoff.

When it comes to regrets, Michael Burry has a few.

The investor of "The Big Short" fame, who bet on GameStop years before it became a meme, explained why he sold the stock before it skyrocketed in a Substack post on Monday night.

Burry got in earlyBurry, who recently pivoted from hedge fund manager to online writer, first invested in GameStop in the summer of 2018. The video-game retailer's stock looked undervalued to him, and he saw an array of catalysts that could send it higher, he wrote.

They included a console refresh in 2020, the possibility of a buyout, the potential sale of the Spring Mobile business, and strong cash flows and a large cash pile offering scope for a "very big and consequential buyback," Burry wrote.

He exited the position in the second quarter of 2019 after the stock failed to budge. But he reinvested in July 2019, buying the stock "with both hands" and making it one of his larger holdings, in part because high short interest presented a fresh catalyst, he wrote.

"I visited a GameStop store to make sure I was not crazy," Burry wrote. "It did not work. Even the stuff that was not on sale looked like it should be on sale."

Burry wrote to GameStop's board to push for changes at the company. He shared that his public activism drew emails from Keith "Roaring Kitty" Gill, a retail investor who would become the face of the GameStop meme mania, and Chewy cofounder Ryan Cohen, who would go on to become GameStop's CEO.

Selling before the surgeBurry said he bought into GameStop the second time at a split-adjusted average price of 83 cents, or less than 1/26 of the current $22 stock price.

He purchased an almost 5% stake and held it for more than 16 months. "Most of that time, I lent my shares out at very good rates — high double digits — which was lucrative and a big part of the trade," he wrote.

Burry cashed out by the end of November 2020, selling his shares for an average of $3.38 each, or more than four times what he paid.

Weeks later, retail investors on forums such as r/WallStreetBets executed a historic squeeze on GameStop short sellers, sending the stock to an intraday high of over $120 on January 28, 2021.

"At the peak my yearslong investment might have turned $12 million into $1 billion, but that was never a possibility," Burry wrote, noting that he would have sold long before that point.

Burry — best known for predicting and profiting from the housing crash that preceded the 2008 financial crisis, a story told in the book and movie "The Big Short" — reflected on whether he should have played his hand differently.

"I could have analyzed that situation better," he said. "I knew GameStop inside and out, and I thought I understood the volume, short interest, and other dynamics. However, I was blinded by what I saw as execution risk."

He'd also lost faith in a huge stock rebound. "As well, I am human," he wrote, adding that large-scale buybacks, board changes, and the sale of Spring Mobile had been "home run/slam dunk activist successes with concrete results but zero impact on price or short interest."

Burry seized the chance to close out his bet after GameStop shares spiked following Cohen's disclosure of his stake.

"I had no idea what was coming," he wrote. "I had no idea that a Roaring Kitty existed."

"And I had no idea that a widely distributed gamma squeeze would thread the needle to become the one and only legal market corner," he added.

Around 50 days after he exited, that "ignominious crappy business" had become the "belle of the ball," Burry wrote. "The entire world could not take their eyes off her. And neither could I."

Looking back and ahead

A GameStop store in Florida.

Jeffrey Greenberg/Universal Images Group via Getty Images

Burry said he had mixed feelings about the meme-stock mania of early 2021: "It was spectacular. It was hilarious. It was tragic in turn."

But he decided it was "less fun" by the middle of 2021, when non-fungible tokens (NFTs) were soaring in value along with "watches, shoes, just about everything."

Burry said he feared retail investors would be "shredded on this meme thing," and warned them to watch out. He spoke out because "if there is one thing I wish I could have done, it was to have effectively warned or spoken about what was happening in 2005-2007," he wrote.

The deep-value investor, who moonlighted as an investment blogger in medical school, also teased an upcoming post that will be a "breakdown of GameStop as an investment today."

"As a melting ice cube and a capital structure with some optionality, GameStop is roughly as I approached it in 2018, except it is only 16% shorted, all the numbers are 10 times bigger and Ryan is running it, for better or worse," he wrote.

Finance

Stocks

GameStop

More

Meme stocks

Investing

Read next

Key Takeaways Global infrastructure growth now spans energy, water, telecom, data centers and public works.DY, STRL, MTZ, EME, and PWR show strong backlogs and visibility into 2026 infrastructure demand.Infrastructure tailwinds include U.S. IIJA funding, grid upgrades and surging data center expansion.
Global infrastructure spending remains structurally strong heading into year-end 2025, supported by aging assets, energy transition mandates, grid resiliency needs and the rapid expansion of data-center capacity. The key investment takeaway is that the “infrastructure cycle” is no longer just roads and bridges—it now includes transmission, distribution, electrification, water and mission-critical facilities that must be built (and rebuilt) over multi-year timelines.

In the United States, public-works visibility extends into 2026 thanks to the Infrastructure Investment and Jobs Act (IIJA), which provides about $350 billion for federal highway programs across fiscal 2022–2026. At the same time, grid modernization is increasingly viewed as a capital “super-cycle,” with major multi-year spending plans tied to reliability and load growth from electrification and data centers.

In Europe, policymakers are explicitly prioritizing faster approvals for grid projects as part of a competitiveness push, while Germany’s construction industry is already pointing to a massive infrastructure investment plan as a catalyst for a 2025–2026 recovery in civil works. The Central Association of the German Construction Industry (ZDB) forecasts a slight real increase in sector turnover of 0.6% this year, reversing three years of decline, followed by a 2.5% surge in 2026. Globally, long-range investment needs remain significant across energy, transport, water, and telecom, reinforcing durable demand for engineering, construction and specialty services leaders.

Against this backdrop, Jacobs Solutions (J - Free Report) is leveraging its engineering and program-management capabilities, record backlog and rising demand across public infrastructure, data centers and advanced manufacturing to support growth into fiscal 2026. Apart from Jacobs, Dycom Industries (DY - Free Report) , Sterling Infrastructure (STRL - Free Report) , MasTec (MTZ - Free Report) , EMCOR Group (EME - Free Report) and Quanta Services (PWR - Free Report) stand out as five companies with differentiated exposure to the most durable areas of infrastructure demand and growing visibility into 2026.

Dycom: Telecom and Data Center Infrastructure at ScaleDycom is emerging as one of the clearest beneficiaries of the next phase of digital infrastructure build-out. Management reported record quarterly results driven by fiber deployment, wireless programs and accelerating demand tied to data centers and hyperscalers. Importantly, Dycom highlighted that it is still in the early stages of what it views as a generational deployment of digital infrastructure, with outside-plant data center networks expected to ramp meaningfully starting in calendar 2026.

Backlog reached an all-time high, supported by diversified bookings across traditional carriers and hyperscaler customers, while BEAD-related broadband funding is moving closer to execution. Management also emphasized the durability of its service and maintenance business, which adds recurring revenue and margin stability. Dycom’s pending acquisition of a mission-critical electrical contractor further expands its reach inside data centers, strengthening its long-term positioning as digital infrastructure spending intensifies through 2026.

Dycom stock has gained 101.6% year to date. The Zacks Consensus Estimate for fiscal 2026 and 2027 EPS has increased to $10.71 (from $10.01) and to $14.45 (from $10.62) over the past 30 days. This indicates 35% growth on 29.2% expected revenue expansion for fiscal 2027. DY stock currently sports a Zacks Rank #1 (Strong Buy) and has a VGM Score of B. You can see the complete list of today’s Zacks #1 Rank stocks here.

Share Price Performance (YTD)

Image Source: Zacks Investment Research

Sterling: High-Margin Exposure to E-InfrastructureSterling continues to pivot successfully toward higher-margin, faster-growing infrastructure markets. Management highlighted exceptional growth in its E-Infrastructure Solutions segment, driven primarily by data center site development and mission-critical projects. This mix shift has supported both margin expansion and strong backlog growth, giving Sterling unusually high visibility relative to its size.

The company’s Transportation segment is also benefiting from steady public-works demand, while its disciplined exit from lower-margin operations has improved overall profitability. Sterling’s backlog growth and expanding pipeline of signed and unsigned awards provide confidence that elevated activity levels can extend into 2026, particularly as data center and power-related projects scale further.

Sterling stock has gained 89.4% year to date (YTD). The Zacks Consensus Estimate for 2026 EPS has increased to $11.95 from $10.98 over the past 60 days, indicating 14.6% growth on 19.1% expected revenue expansion. STRL stock currently flaunts a Zacks Rank #1.

MasTec: Diversified Infrastructure with Power & Communications TailwindsMasTec offers one of the most diversified infrastructure platforms in the group, spanning communications, power delivery, clean energy, pipelines and industrial infrastructure. Management pointed to strong execution across non-pipeline segments, with communications and power delivery benefiting from broadband expansion, grid modernization and data center-related power demand.

Critically, MasTec emphasized that reported backlog understates longer-term visibility, particularly in power and pipeline projects that are expected to ramp in 2026. The company continues to see substantial capital commitments across transmission, substations, renewables and gas-fired generation, all of which position it to capture incremental spending as infrastructure investment accelerates.

MasTec stock has gained 61.9% YTD. The Zacks Consensus Estimate for 2026 EPS has increased to $8.12 from $7.83 over the past 60 days, indicating 27.3% growth on 8.4% expected revenue expansion. MTZ stock currently carries a Zacks Rank #3 (Hold) and has a VGM Score of B.

EMCOR: Margin Strength Meets Data Center DemandEMCOR stands out for its combination of execution discipline, margin resilience and expanding exposure to data centers and mission-critical facilities. Management highlighted record remaining performance obligations, driven largely by network, communications and data center projects, where demand has nearly doubled year over year.

The company’s electrical and mechanical construction businesses are benefiting from strong project mix, prefabrication capabilities and disciplined contract selection. EMCOR’s service businesses add recurring revenue and cushion cyclical swings, while its balance sheet strength allows for continued investment and acquisitions. With data center, healthcare and manufacturing projects driving backlog growth, EMCOR appears well-positioned for sustained infrastructure demand into 2026.

EMCOR stock has gained 37.5% YTD. The Zacks Consensus Estimate for 2026 EPS has increased to $27.41 from $27.08 over the past 60 days, indicating 8.6% growth on 5.7% expected revenue expansion. EMCOR stock currently carries a Zacks Rank #3 and has a VGM Score of B.

Quanta Services: A Leader in Power Grid and ElectrificationQuanta Services sits at the center of one of the most capital-intensive infrastructure cycles in decades. Management reported record backlog as utilities, industrial customers, and large power users accelerate investment in transmission, generation and electrification. Demand is being driven by data centers, reshoring, electric vehicles and aging grid infrastructure.

Quanta’s integrated, self-perform model and craft-skilled workforce give it a competitive advantage in executing complex, large-scale projects. Management also highlighted expanding opportunities in power generation and grid solutions as electricity demand rises sharply. With visibility extending well beyond 2025, Quanta appears positioned to remain a core beneficiary of infrastructure spending through 2026 and beyond.

Quanta stock has gained 37.9% YTD. The Zacks Consensus Estimate for 2026 EPS has increased to $12.38 from $12.31 over the past 60 days, indicating 16.9% growth on 11% expected revenue expansion. Quanta stock currently carries a Zacks Rank #3 and has a VGM Score of B.

December 16, 2025 08:30 ET

 | Source:

Day One Biopharmaceuticals, Inc.

BRISBANE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that Dr. Jeremy Bender, chief executive officer, will present during the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12 at 5:15 p.m. Pacific Time / 8:15 p.m. Eastern Time.

A live audio webcast of the presentation will be available by visiting the News & Events section of the Company’s website at  www.dayonebio.com. An archived replay of the webcast will be available for 30 days following the live presentation.

About Day One Biopharmaceuticals
Day One Biopharmaceuticals is a commercial-stage biopharmaceutical company that believes when it comes to pediatric cancer, we can do better. The Company was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug development and redefine what’s possible for all people living with cancer—regardless of age—starting from Day One.

Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The Company’s pipeline includes tovorafenib (OJEMDA™) and DAY301.

Day One is based in Brisbane, California. For more information, please visit www.dayonebio.com or find the Company on LinkedIn or X.

Day One uses its Investor Relations website (ir.dayonebio.com), its X handle (x.com/DayOneBio), and LinkedIn Home Page (linkedin.com/company/dayonebio) as a means of disseminating or providing notification of, among other things, news or announcements regarding its business or financial performance, investor events, press releases, and earnings releases, and as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD.

DAY ONE MEDIA
[email protected]

DAY ONE INVESTORS
LifeSci Advisors, PJ Kelleher
[email protected]

, /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that its therapeutic research arm, Caris Discovery, has entered into a multi-year collaboration and license agreement with Genentech, a member of the Roche Group. In this collaboration, Caris will work to identify and validate novel oncology targets in solid tumor tissue.

Under the terms of the agreement, Caris is eligible to receive upfront and near-term payments of $25 million and is also eligible for up to $1.1 billion of potential research, development, commercial and net sales milestone payments, as well as potential tiered royalties on net sales of collaboration therapies.

"At Caris, we are committed to making precision medicine a reality for all patients. This innovative collaboration with Genentech is specifically designed to identify and validate novel targets in solid tumors. By combining Caris' unparalleled multimodal data and tissue-based discovery engine with Genentech's deep expertise in therapeutics development, we hope to enable the development of first-in-class medicines for cancer patients," said Milan Radovich, PhD, Senior Vice President and Chief Scientific Officer at Caris.

"Roche and Genentech are driven by a profound vision - a future where cancer can be cured," said Boris L. Zaïtra, Head of Roche Corporate Business Development. "We have successfully led many fundamental scientific advances in oncology. As we continue to bring forth transformative medicines, collaborations with partners such as Caris allow us to pursue future innovation for patients with unmet needs."

Caris is able to leverage insights from its extensive repository of nearly 500,000 solid tumor samples, along with matched comprehensive molecular and clinical data, to offer sophisticated and flexible target discovery capabilities leveraging both tissue-based and data-centric techniques to biopharma partners. Caris Discovery scientists use an integrated bioinformatics and wet-lab workflow, which combines interrogation of solid tissue and cell-based systems with multimodal data to validate prioritized targets and help advance the development of next generation therapies.

About Caris Life Sciences  
Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms at scale, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies, and high-performance computing provides a differentiated platform to develop the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development.  

Caris was founded with a vision to realize the potential of precision medicine in order to improve the human condition. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S. and other international markets.  

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical facts contained in this press release are forward-looking statements, including statements regarding our strategy, benefits of our collaboration with Genentech and potential milestone payments. In some cases forward-looking statements can be identified by words such as "may," "will," "should," "would," "expect," "plan," "anticipate," "could," "intend," "target," "project," "potential," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or similar expressions. 

You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in these forward-looking statements are reasonable based on information currently available to us, we cannot guarantee that the future results, discoveries, levels of activity, performance or events and circumstances reflected in forward-looking statements will be achieved or occur. Forward-looking statements involve known and unknown risks and uncertainties, some of which are beyond our control. Potential milestone payments described herein are contingent upon Genentech's discretionary advancement decisions at multiple stages and achievement of development, regulatory, and commercial milestones, with no assurance that any targets will progress through the full pipeline.  Risks and uncertainties that could cause our actual results to differ materially from those indicated or implied by the forward-looking statements in this press release include, among other things: the parties' ability to successfully execute the research plan and achieve target discovery milestones; Genentech's decisions regarding target designation, acceptance, and licensing; technical challenges in target validation and regulatory requirements relating to drug development; the uncertainty in translating research discoveries into commercial products and the risk that targets do not progress through the full development pipeline or result in further payments to Caris; developments in the precision medicine industry; our future financial performance, results of operations or other operational results or metrics; development, analytical and clinical validation, timing and performance of future solutions by us and our competitors; commercial market acceptance for our solutions, including acceptance of preventive as well as diagnostic testing paradigms, and our ability to meet resulting demand; the rapidly evolving competitive environment in which we operate; third-party payer reimbursement and coverage decisions related to our solutions; risks related to data management, storage, and processing capabilities and our ability to integrate and deploy artificial intelligence and advanced data analytics technologies; our ability to protect and enhance our intellectual property; regulatory requirements, decisions or approvals (including the timing and conditions thereof) related to our solutions; reliance on third-party suppliers; risks related to data security, patient privacy, and compliance with healthcare data protection regulations as well as potential cybersecurity threats to our data platforms; our compliance with laws and regulations; the outcome of government investigations and litigation; risks related to our indebtedness; and our ability to hire and retain key personnel as well as risks, uncertainties, and other factors described in the section titled "Risk Factors" and elsewhere in our Quarterly Report on Form 10-Q filed on or about November 5, 2025, and in our other filings we make with the SEC from time to time. We undertake no obligation to update any forward-looking statements to reflect changes in events, circumstances or our beliefs after the date of this press release, except as required by law.

Caris Life Sciences Media:   
Corporate Communications 
[email protected] 
214.294.5606  

SOURCE Caris Life Sciences

, /PRNewswire/ -- GreenPower Motor Company Inc. (Nasdaq: GP) ("GreenPower"), a leading manufacturer and distributor of all-electric, purpose-built, zero-emission medium and heavy-duty vehicles serving the cargo and delivery market, shuttle and transit space and school bus sector, today announced that its EV Star line of products are eligible for up to $130,000 in incentives under the Clean Truck and Bus Voucher Incentive Project (HVIP). The HVIP program reopened today with more than $140 Million in available incentives. 

GreenPower's EV Star Passenger Van, EV Star Reefer-X, and EV Star Cab Chassis.

GreenPower has a full lineup of Class 4 all-electric, purpose-built, zero-emission commercial vehicles eligible for the incentives including the EV Star Passenger Van, the EV Star Mobility Plus, the EV Star ReeferX, the EV Star Cab & Chassis, the EV Star Stakebed Truck and the EV Star Utility Truck, among other options. 

The new round of Standard HVIP funding opens more than $140 million to fleets of all sizes. Fleets with 20 or more medium and heavy-duty vehicles are eligible for base vouchers of $60,000 per Class 4 zero-emission vehicle, with the ability to hold up to 20 unredeemed vouchers at a time. Funding will be available on a first-come, first-served basis, and past funding rounds have depleted fast, so fleets should have their documentation ready and be prepared for a dealer to submit voucher requests as soon as the window opens.

Small business fleets defined as private operators with 20 or fewer medium and heavy-duty vehicles and less than $15 million in annual revenue, remain eligible for vouchers of up to $130,000 per Class 4 zero-emission commercial vehicle. Under the Innovative Small E-Fleet (ISEF) program, which supports flexible, lower-risk pathways for smaller operators to adopt zero-emission vehicles, $20 million will be available. ISEF funding can be used for innovative solutions such as short-term leases, vehicle rentals, truck-as-a-service models and bundled offerings that include charging support, helping fleets overcome early cost and infrastructure hurdles.

"GreenPower offers a full lineup of commercial, all-electric, purpose-built, zero-emission vehicles to fit a wide range of fleet needs," said Nahui Olin, GreenPower Vice President of Business Development & Commercial Operations. "Passenger models, including the EV Star Passenger Van and EV Star Mobility Plus, are available now with multiple seating and ADA configurations. GreenPower's commercial cargo, goods, and refrigerated vehicles, built on the proprietary EV Star Cab & Chassis, are also available for immediate delivery. Fleets can choose from box trucks, refrigerated units, utility and stake bed trucks and other upfit options. We are happy and ready to work with customers and their upfitters to build a vehicle that fits their exact requirements"

With funding expected to move quickly, fleets that have been waiting for new Standard HVIP funding should act now to improve their chances of securing support. Medium and large fleets with 20 or more medium and heavy-duty vehicles face especially high demand since Standard HVIP funding covers multiple vehicle classes and is open to fleets of all sizes. "If your fleet has been waiting for funding to reopen, now is the time to move. Being prepared on day one makes a real difference in securing funding before it runs out," Olin concluded.

For further information on GreenPower's EV Star line of products and on maximizing the use of the HVIP incentives, contact Nahui Olin at [email protected].

For further information contact:

Nahui Olin, VP Business Development & Commercial Operations
[email protected] 

Brendan Riley, President
(510) 910-3377

Fraser Atkinson, CEO
(604) 220-8048

About GreenPower Motor Company Inc.
GreenPower designs, builds and distributes a full suite of high-floor and low-floor all-electric medium and heavy-duty vehicles, including transit buses, school buses, shuttles, cargo van and a cab and chassis.  GreenPower employs a clean-sheet design to manufacture all-electric vehicles that are purpose built to be battery powered with zero emissions while integrating global suppliers for key components. This OEM platform allows GreenPower to meet the specifications of various operators while providing standard parts for ease of maintenance and accessibility for warranty requirements. For further information go to www.greenpowermotor.com

Forward-Looking Statements
This document contains forward-looking statements relating to, among other things, GreenPower's business and operations and the environment in which it operates, which are based on GreenPower's operations, estimates, forecasts and projections. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as "upon", "may", "should", "will", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. A number of important factors including those set forth in other public filings Company's public documents including those filed on SEDAR+ at www.sedarplus.ca and with the United States Securities and Exchange Commission filed on EDGAR at www.sec.gov could cause actual outcomes and results to differ materially from those expressed in these forward-looking statements. Consequently, readers should not place any undue reliance on such forward-looking statements. In addition, these forward-looking statements relate to the date on which they are made. GreenPower disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

©2025 GreenPower Motor Company Inc. All rights reserved.

SOURCE GreenPower Motor Company

December 16, 2025 08:30 ET

 | Source:

SAIC, Inc.

RESTON, Va., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corporation (NASDAQ: SAIC), a premier Fortune 500® company driving our nation's digital transformation across the defense, space, intelligence, and civilian markets, today announced the appointment of Ravi Dankanikote as the company’s Chief Growth Officer, effective immediately. He will report to Interim SAIC Chief Executive Officer Jim Reagan.

In this role, Dankanikote will lead SAIC’s enterprise growth strategy and go-to-market approach. He brings more than 30 years of growth leadership experience in the GovCon space, with a proven track record of building winning, customer-centric business development organizations. He is widely recognized for his deep understanding of mission requirements, forward-leaning solution design, and ability to unify growth investments around long-term enterprise goals.

Dankanikote previously served as SAIC’s Senior Vice President for Business Development from 2021 until August of this year. He returns to SAIC from Peraton, where he served as Chief Growth Officer for the past four months. Prior to joining SAIC in 2021, he spent 27 years at CACI serving in multiple senior business development and growth roles.

“Ravi doesn’t just know SAIC, he knows the industry. He is deeply attuned to industry trends and the transformation that is occurring right now in the market in terms of what customers want and how they want to purchase it,” said Reagan. “He is the right choice to lead our business development and growth strategy as SAIC implements our simplified organizational structure and sharpens our focus on key opportunities to provide even greater value to our customers, increase growth for our shareholders, and create a stronger company.”

“SAIC’s market leadership, deep mission expertise, and world-class talent uniquely position us to shape the future of national security. By fusing cutting-edge commercial innovation with trusted delivery customers, we have a powerful opportunity to drive mission outcomes, accelerate modernization, and deliver sustainable growth for all stakeholders,” said Dankanikote.

Dankanikote holds a Master of Science degree in Computer Science from Shippensburg University and a Bachelor of Engineering degree from R.V. College of Engineering in Bangalore, India. He is active in the national security ecosystem, serving on the Board of Directors for the Washington Chapter of NDIA, WashingtonExec and Executive Mosaic’s BD Council, and other mission-focused nonprofits.

About SAIC
SAIC® is a premier Fortune 500® mission integrator focused on advancing the power of technology and innovation to serve and protect our world. Our robust portfolio of offerings across the defense, space, civilian and intelligence markets includes secure high-end solutions in mission IT, enterprise IT, engineering services and professional services. We integrate emerging technology, rapidly and securely, into mission critical operations that modernize and enable critical national imperatives.

We are approximately 24,000 strong; driven by mission, united by purpose, and inspired by opportunities. Headquartered in Reston, Virginia, SAIC has annual revenues of approximately $7.5 billion. For more information, visit saic.com. For ongoing news, please visit our newsroom.

Investor Relations Contact:
Joe DeNardi
[email protected]

Media Contacts:
Caralyn Duke 
[email protected]

Forward-Looking Statements

Certain statements in this release contain or are based on “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “guidance,” and similar words or phrases. Forward-looking statements in this release may include, among others, estimates of future revenues, operating income, earnings, earnings per share, charges, total contract value, backlog, outstanding shares and cash flows, as well as statements about SAIC’s ability to realize growth opportunities as a result of the new organizational structure. Such statements are not guarantees of future performance and involve risk, uncertainties and assumptions, and actual results may differ materially from the guidance and other forward-looking statements made in this release as a result of various factors. Risks, uncertainties and assumptions that could cause or contribute to these material differences include those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Legal Proceedings” sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission (the “SEC”), which may be viewed or obtained through the Investor Relations section of our website at saic.com or on the SEC’s website at sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. SAIC expressly disclaims any duty to update any forward-looking statement provided in this release to reflect subsequent events, actual results or changes in SAIC’s expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.

December 16, 2025 08:30 ET

 | Source:

CytoDyn Inc.

VANCOUVER, Washington, Dec. 16, 2025 (GLOBE NEWSWIRE) --

Dear Shareholders,

As we close out the year and step with confidence and purpose into 2026, I want to extend my sincere appreciation for your support, patience, and continued belief in CytoDyn’s (the “Company”) mission. I will remember 2025 as the year in which we first presented our astonishing survival observations and compelling data on the emerging role of leronlimab in solid tumor oncology. This past year has been one of disciplined execution, operational rebuilding, and meaningful scientific progress. Today, we are a far stronger, more focused, and more capable company than we were twelve months ago.

In February, we announced increased survival rates in patients with metastatic Triple-Negative Breast Cancer (“mTNBC”) who were treated with leronlimab in prior studies. In May, after further evaluation of the underlying data and treatment profiles on the group of long-term survivors, we shared our exciting new proposed mechanism of action (“MOA”) for leronlimab. Among the long-term survivors with sustained remission, we observed three common factors: (i) treatment with leronlimab, (ii) subsequent expression of PD-L1 levels on circulating tumor cells above a common threshold, and (iii) treatment with an immune checkpoint inhibitor (“ICI”). All five patients who were treated in this manner are alive today, five years later, and three of these individuals currently show no evidence of disease. The patient profiles and underlying data, albeit retrospective, suggest that leronlimab can convert “cold” (PD-L1–negative) tumors into “hot” (PD-L1–positive) tumors by blocking CCR5, thereby enabling a potential “prime and pair” regimen in which leronlimab primes the tumor microenvironment which then allows ICIs to unleash an immune response.

Once prospectively confirmed, leronlimab’s ability to induce a “hot” tumor microenvironment should be a game changer in solid tumor oncology. This is our top clinical priority, and data supporting this concept are being collected in our active Phase 2 colorectal cancer (“CRC”) trial and will be collected in our Phase 2 mTNBC trial set to commence in 2026.

Calendar 2025 in Review

Throughout 2025, our team delivered on several critical priorities designed to restore momentum and position CytoDyn for long-term success:

Operational Strengthening. We advanced essential regulatory preparations, refined our clinical strategy, and improved internal processes. This included strengthening data integrity standards, enhancing trial oversight, and engaging more consistently and constructively with regulators and investigators.

Clinical Program Advancement. Our scientific team made significant progress across our therapeutic focus areas. While early-stage milestones rarely generate headlines, this foundational work ultimately determines a biotech company’s trajectory. By improving study design, aligning with clinical experts, and prioritizing areas of unmet need, we have created a roadmap that is realistic, executable, and value-creating. A detailed Clinical Update supplement is attached at the end of this letter.

Financial Discipline. 2025 was marked by prudent financial stewardship. We remained focused on extending our runway, improving our cost structure, and ensuring that resources are directed toward programs with the highest probability of success and the greatest potential benefit for patients.

The progress we made this year is tangible. As we continue towards prospectively confirming our MOA theories, the progress above is not theoretical and our team has positioned the company to move confidently into its next phase. We have tightened operations, clarified our approach, strategically resolved legal issues, and established the infrastructure needed to deliver meaningful results. Our optimism for 2026 is grounded firmly in the work completed in 2025.

Looking Ahead to Calendar 2026

As we enter 2026, CytoDyn stands on the cusp of several important clinical and regulatory inflection points. I am optimistic about the near-term milestones ahead, including:

Advancements in our ongoing clinical studies
Near-term data readouts towards prospectively confirming our MOA theories
Continued progress in regulatory interactions that may unlock new clinical pathways
Strengthening relationships with key clinicians, investigators, and potential partners With the fundamentals in place and our programs advancing, 2026 is poised to be the year CytoDyn re-enters the industry conversation with force and credibility. We believe the coming year will showcase:

Strong clinical execution
Clear scientific validation
Data-driven milestones
Pathways that may enable new opportunities with clinicians, researchers, and industry partners Biotech requires rigor, patience, and adherence to the regulatory process, but we have every reason to believe that the groundwork laid in 2025 will begin to show tangible results in 2026.

Closing Thoughts
Thank you for standing with us. Thank you for believing in our mission to develop therapies with the potential to improve lives. And thank you for your continued commitment to CytoDyn as we enter what I believe will be the most important and transformative year in our company’s history. We are ready. We are focused. And in 2026, we intend to make waves.

Wishing everyone a safe and joyful holiday season,
Jacob Lalezari, MD
CEO

Note Regarding Forward-Looking Statements 
This news release contains forward-looking statements relating to, among other things, the mechanism of action of leronlimab, clinical trial results, product development, market position, future operating and financial performance, and business strategy. The reader is cautioned not to rely on these statements, which are based on current expectations of future events. For important information about these statements and our Company, including the risks, uncertainties and other factors that could cause actual results to vary materially from the assumptions, expectations and projections expressed in any forward-looking statements, the reader should review our Annual Report on Form 10-K for the fiscal year ended May 31, 2025, including the section captioned “Forward-Looking Statements” and in Item 1A, and in subsequent reports filed with the Securities and Exchange Commission. CytoDyn Inc. does not undertake to update any forward-looking statement as a result of new information or future events or developments other than as required by law. 

Corporate Contact 
CytoDyn Inc. 
[email protected]

Media Contacts 
David Schull or Ignacio Guerrero-Ros, Ph.D. 
Russo Partners, LLC 
[email protected] 

Clinical Update
– December 2025 –

Our Phase II study of patients with mCRC was launched in July 2025, to evaluate the safety and efficacy of leronlimab (350 mg versus 700 mg) added to a backbone of Bevacizumab and Tipiracil. As of this writing, the study has enrolled 16 patients with another 23 patients in screening. Based upon current projections, we anticipate 20 patients to be enrolled by the end of the year, and to have the trial fully enrolled in or around May 2026.

Early results from the mCRC trial have been very encouraging, and we have already submitted abstracts for at least two presentations on the CRC study in 2026– one presentation on biomarker results, and a second focused on clinical outcomes. In addition, the study design is being amended so that patients who have a clinical progression will have the option of adding an ICI to their treatment regimen. As a result, the final CRC study design will allow us to evaluate leronlimab both as a “stand-alone” agent on its own (added to the background regimen) and as a “prime and pair” agent used in conjunction with ICIs.

We recently received feedback from FDA on two proposed protocols for patients with mTNBC, including a Phase II study combining leronlimab with ICIs as well as an Expanded Access Program (EAP). We are incorporating FDA’s helpful comments and will be submitting revised protocols for both initiatives in the near future.

The Phase 2 trial in patients with mTNBC will enroll individuals onto a dosing regimen of weekly leronlimab along with chemotherapy for several cycles after which time they will be randomized to immediate versus deferred treatment with an ICI. The primary endpoint of the study will be clinical evaluation of Overall Response Rate (ORR) with secondary endpoints including both Progression-Free Survival (PFS) and Overall Survival (OS). Two exploratory endpoints will include evaluation of changes in PD-L1 on circulating tumor cells as well as changes in circulating tumor DNA (ctDNA). This study is intentional and dynamic, meant to provide prospective confirmation of the “prime and pair” paradigm that we believe will be of particular interest to potential industry partners, as well as evaluate leronlimab’s potential for monotherapy benefit.

With Every Patient (WEP Clinical) has been engaged to serve as our clinical research organization (CRO) for the EAP, and we expect to open the program for patient referral in or around February 2026, assuming FDA’s allowance of our revised protocol submission. In addition to providing compassionate access to patients who have exhausted other treatment options and are otherwise unable to participate in our upcoming Phase 2 trial, the EAP program will serve as another potential avenue to observe PD-L1 induction following treatment with leronlimab, and thereby – in theory – opening a treatment pathway towards sustained remission when combined with an ICI. As previously shared, we are grateful to a high-net worth individual who has agreed to cover the cost of the first 20 patients enrolled in this two-year program.

In 2025 there was a marked increase in incoming requests for CytoDyn to collaborate with investigators from a variety of academic centers. I am pleased to announce that we are proceeding with four such initiatives, and that all four are being funded in part or entirely by outside third parties. First, an investigator at City of Hope has received institutional approval for a study of subcutaneous leronlimab given in combination with a regimen of chemotherapy administered through the hepatic artery in treatment-naïve patients with mCRC who have metastatic disease confined to the liver. This study seeks to leverage CytoDyn’s previously announced data demonstrating leronlimab’s ability to mitigate liver toxicity in prior preclinical studies, as well as certain preliminary results from the phase II CRC study. This study is intended to provide CytoDyn with important tumor tissue from patients treated with leronlimab. This tissue will enable us to correlate tumor levels of PD-L1 with levels concurrently measured in blood on circulating tumor cells. This tissue will also provide CytoDyn the opportunity to further clarify and understand the leronlimab-induced changes in the tumor microenvironment (TME) that lie at the heart of the “Prime and Pair” paradigm.

Second, in keeping with our focus on solid tumor oncology, CytoDyn is collaborating with several academic centers on a pilot study of patients with recurrent Glioblastoma. This study proposes to treat patients with leronlimab in advance of their scheduled surgery for recurrent disease. After surgery, patients will begin treatment with an ICI in the hope that a leronlimab-disrupted TME can then be treated with an ICI and provide clinical benefit to patients.

In addition to the above, CytoDyn has been working with several investigators on two exciting projects outside oncology. Our collaborator at Cornell has finalized a 12-week pilot study of leronlimab in patients with mild to moderate Alzheimer’s Disease. All the necessary approvals have been received, and the study is scheduled to begin screening after requisite equipment is installed at Cornell in April 2026.

Lastly, we continue work with Dr. Jonah Sacha, and others at Oregon Health Sciences University and the University of Washington, on an HIV cure project involving stem cell transplantation. The final protocol is now complete and submission to both institutional IRBs and FDA will commence shortly.

Upon closing, Eric M. Jackson to Lead Combined Company as Chief Executive Officer and Chairman

December 16, 2025 08:30 ET

 | Source:

SRx Health Solutions, Inc.

NORTH PALM BEACH, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced that it has entered into a definitive agreement to acquire EMJ Crypto Technologies (“EMJX”), a digital-asset treasury platform designed as a treasury operating system, applying quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Upon completion of the transaction, Eric M. Jackson, Ph.D., Founder and Chief Executive Officer of EMJX, is expected to serve as Chief Executive Officer and Chairman of the combined company.

A Gen2 Approach to Digital Asset Treasuries:
EMJX is designed as a next-generation (“Gen2”) digital-asset treasury platform, differentiated from earlier “Gen1” treasury models that primarily hold a single digital asset on a passive basis. EMJX’s Gen2 approach is structured as a platform that governs how capital is allocated, hedged, and reinvested across market cycles, rather than functioning as a passive balance sheet tracking asset values. Gen1 treasury approaches largely rely on price appreciation of a single asset and typically lack systematic risk management, which can expose shareholders to significant drawdowns and dilution during adverse market conditions.

By contrast, EMJX is structured to support:

multi-asset digital holdings,quantitative and AI-informed decision-making, andsystematic risk management across market regimes, with the objective of managing treasury exposure through periods of both market expansion and contraction.
The Company believes this Gen2 framework reflects the continued maturation of digital-asset treasuries toward more disciplined, institutional-grade capital management models.

Eric M. Jackson, Founder and CEO of EMJX, said, “Every major technology category goes through generational transitions. In digital assets, we believe the next phase is defined by disciplined risk management and multi-asset flexibility rather than single-asset exposure alone. Many digital-asset treasuries today function more like passive markers in the market — they rise and fall with price movements. EMJX is designed to operate more like a vessel with navigation systems, applying quantitative models and AI-enabled risk controls to help manage volatility across market cycles. Our objective is to reinvest capital back into the treasury over time rather than rely on dilution, and to build a transparent, institutional-grade platform with a long-term orientation. Platforms aren’t valued on what they hold – they’re valued on what they enable.”

Capital Discipline and Treasury Compounding:
As a treasury operating system, EMJX is designed to manage risk and capital allocation at the system level rather than through asset-by-asset trading. The platform applies quantitative risk-management tools, including hedging strategies, with the objective of mitigating drawdowns during periods of market stress.

When these risk-management activities generate excess capital, the Company intends to allocate that capital back into its digital-asset treasury rather than relying on equity issuance, subject to market conditions, governance oversight, and regulatory considerations. The Company believes this approach may allow the treasury to compound over time while reducing the need for shareholder dilution that has historically accompanied single-asset, unhedged treasury models.

Founder Track Record and Market Insight:
EMJX was founded by Eric M. Jackson, Ph.D., a long-time technology investor and market analyst known for identifying inflection points in misunderstood public companies before they became widely recognized.

Over the past several years, Dr. Jackson publicly identified and analyzed a number of non-consensus opportunities that later experienced significant market re-ratings, including Carvana, Opendoor, Better Home & Finance, and Nextdoor. His work around Opendoor helped catalyze a large, engaged retail investor community commonly referred to as the “OPEN Army,” which emphasized long-term conviction, transparency, and platform-level analysis over short-term trading.

That same analytical framework underpins the Rising Dynasty philosophy — a research-driven approach focused on power-law outcomes, structural change, and disciplined risk awareness. EMJX applies these principles to the digital-asset treasury space through quantitative systems rather than discretionary positioning.

Dr. Jackson is a frequent commentator on technology and market structure and has appeared on major financial media outlets including CNBC, Bloomberg, and Fox Business.

Platform Development:
EMJX’s digital-asset treasury operating system is powered by its proprietary Quantitative AI and Machine Learning (QAM) Engine, which has been developed and refined since 2021. The QAM Engine is designed to analyze market conditions and inform portfolio-level risk-management decisions across multiple digital assets, subject to governance and oversight.

The Company emphasizes that the platform’s objective is risk-aware treasury management, not short-term speculation.

Strategic Rationale:
The transaction is intended to position the combined company at the intersection of:

digital-asset treasury management,quantitative and AI-enabled risk systems, andpublic-market transparency and governance.
The Company believes digital-asset treasuries are entering a new phase, where survivability through volatility, disciplined capital allocation, and long-term compounding — rather than simple asset exposure — become the defining competitive advantages. The Company believes the long-term value of EMJX will be driven not by the digital assets held at any point in time, but by the risk-management, capital-routing, and compounding capabilities the platform enables over full market cycles.

Transaction Details:

The SRx Health Board of Directors has unanimously approved the transaction.The transaction is subject to approval by SRx Health shareholders and other customary closing conditions.Closing is expected during the first quarter of 2026.Until closing, SRx Health shares will continue to trade on NYSE American under the symbol “SRXH.”Following completion, the combined company expects to operate under the EMJX name and intends to pursue a ticker symbol change, subject to exchange approval.
About EMJX
EMJX is a Gen2 digital-asset treasury operating system designed to manage multi-asset digital holdings using quantitative models, artificial intelligence, and systematic risk controls. The platform emphasizes transparency, governance, and disciplined capital allocation across varying market environments. For more information, please visit www.emjx.ai.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer

Investor Relations
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
[email protected]

Media Contact
KCSA Strategic Communications
Kristin Cwalinski, Senior Vice President
[email protected]

December 16, 2025 08:30 ET

 | Source:

SEALSQ

Geneva, Switzerland, Dec. 16, 2025 (GLOBE NEWSWIRE) --

Total QS7001 & Qvault TPM Pipeline of $49.8 Million out of a Total Pipeline of Approximately $200 Million, as of December 15, 2025

SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today provided an update on the accelerated market adoption of its cutting-edge post-quantum secure chip, the “Quantum shield - QS7001.” The Company is witnessing significant global traction from industry partners, system integrators, and technology OEMs seeking robust security solutions to face upcoming quantum computers capability to break current encryption technology.

SEALSQ has strengthened its collaboration network with industry consortia, integrators, and standards bodies to accelerate scalable deployment of its quantum-resistant products worldwide and has entered into commercial discussions with up to 115 potential customers who have expressed strong interest. Adoption spans multiple continents, with deployments and pilot programs underway in North America, Europe, and Asia Pacific.

Initially unveiled at the IQT Quantum + AI Conference in New York on October 20, 2025, the QS7001's commercial launch was announced during a dedicated event at the Las Vegas Grand Prix on November 21, 2025, where the first development kits were made available to customers for integration and application development. Since the commercial launch, has seen a surge in the number of qualified leads and design-ins and, leading to the growth of pipeline of opportunities for QS7001 and Qvault TPM to $49.8 million as of December 15, 2025, for the period covering 2026 to 2028, up from approximately $11.4 million at the same time in the previous year, a strong indicator of accelerating demand for quantum‑resistant security solutions among global OEMs and enterprise customers. The QS7001 and Qvault TPM forms part of SEALSQ’s total pipeline that, today, sits at an estimated $200 million for the period covering 2026 to 2028.

The product has been well received by global partners and OEMs through the testing period, including Eviden (Atos Group), Authentrend, Capgemini Engineering, ColibriTD, FortifyIQ Inc., Granite River Labs, Kaynes Semiconductor, Landis+Gyr, Metavisio (Thomson Computing), PORTYQ, Quantix Edge Security, Serma Security, Trusted Semiconductor Solutions, and manufacturing partner UMC.

Leveraging a secure 32-bit RISC-V core, the QS7001 delivers up to 10× higher performance than software-based post-quantum implementations, while offering enhanced resistance to side-channel attacks and physical tampering. It aims at enabling compliance for device makers with emerging post quantum mandates like CNSA 2.0 and is adapted to resource-constrained environments such as IoT, cryptocurrencies, defense, healthcare, and critical infrastructure.

SEALSQ is taking the lead in the industry with the QS7001 to become a key player of any quantum-resistant security strategy, targeting a potential market of over 21 billion of devices currently connected worldwide that could require immediate protection against “Harvest Now, Decrypt Later” threats. As per IOT Analytics, the installed base of connected IoT devices could reach about 32 billion – 40 billion by 2030, implying roughly a doubling from current levels. Growth is driven by expanding 5G coverage, cheaper sensors, and adoption in areas like manufacturing, logistics, energy, smart homes, and cities.

“Organizations recognize that the quantum computing era is approaching faster than expected,” said Carlos Moreira CEO and founder of SEALSQ. “OurQS7001 secure chip is uniquely positioned to deliver practical, standards-aligned post-quantum security today, and we’re seeing real momentum as enterprises move from planning to implementation and begin deploying quantum-safe protections across their most critical workloads.”

With strong design-win momentum, a deepening partner ecosystem, and international deployments, SEALSQ reaffirms its commitment to enabling quantum-resilient security solutions that protect data, devices, and services across digital environments.

For more information on QS7001 and SEALSQ’s post-quantum offerings, visit www.sealsq.com.

About SEALSQ:
SEALSQ is a leading innovator in Post-Quantum Technology hardware and software solutions. Our technology seamlessly integrates Semiconductors, PKI (Public Key Infrastructure), and Provisioning Services, with a strategic emphasis on developing state-of-the-art Quantum Resistant Cryptography and Semiconductors designed to address the urgent security challenges posed by quantum computing. As quantum computers advance, traditional cryptographic methods like RSA and Elliptic Curve Cryptography (ECC) are increasingly vulnerable.

SEALSQ is pioneering the development of Post-Quantum Semiconductors that provide robust, future-proof protection for sensitive data across a wide range of applications, including Multi-Factor Authentication tokens, Smart Energy, Medical and Healthcare Systems, Defense, IT Network Infrastructure, Automotive, and Industrial Automation and Control Systems. By embedding Post-Quantum Cryptography into our semiconductor solutions, SEALSQ ensures that organizations stay protected against quantum threats. Our products are engineered to safeguard critical systems, enhancing resilience and security across diverse industries.

For more information on our Post-Quantum Semiconductors and security solutions, please visit www.sealsq.com.

Forward-Looking Statements
This communication expressly or implicitly contains certain forward-looking statements concerning SEALSQ Corp and its businesses. Forward-looking statements include statements regarding our business strategy, financial performance, results of operations, market data, events or developments that we expect or anticipate will occur in the future, as well as any other statements which are not historical facts. Although we believe that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond our control. Actual results may differ materially from those expressed or implied by such forward-looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include SEALSQ's ability to continue beneficial transactions with material parties, including a limited number of significant customers; market demand and semiconductor industry conditions; and the risks discussed in SEALSQ's filings with the SEC. Risks and uncertainties are further described in reports filed by SEALSQ with the SEC.

SEALSQ Corp is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

SEALSQ Corp.
Carlos Moreira
Chairman & CEO
Tel: +41 22 594 3000
[email protected] Investor Relations (US)
The Equity Group Inc.
Lena Cati
Tel: +1 212 836-9611
[email protected]

Hong Kong, Dec. 16, 2025 (GLOBE NEWSWIRE) -- MasterBeef Group (“MasterBeef” or the “Company”) (Nasdaq: MB), a full-service restaurant group in Hong Kong, specializing in Taiwanese hotpot and Taiwanese barbecue, announced today the results of the Company’s Annual General Meeting of Members (the “AGM”) held on December 12, 2025, at the law firm of Taylor Wessing, located at 21st Floor, 8 Queen’s Road Central, Hong Kong on 12 December 2025 at 11:00 a.m. (Hong Kong Appointment of Board of Directors.

At the AGM, the Company’s members approved and ratified the appointment of the following seven (7) persons to serve as directors of the Company until the next annual meeting of Members and thereafter until their successors shall have been elected and qualified: (i) Oi Wai Chau, Executive Director; (ii) Oi Yee Chau, Executive Director; (iii) Tsz Kiu So, Executive Director; (iv) Lok Ming Leung; (v) Man Fai Danny Liu; (vi) Hiu Wa Chan; and (vii) Chung Fan Cheng.

Ratification of Appointment of OneStop Assurance PAC

At the AGM, the Company’s members also approved an ordinary resolution to ratify the appointment of OneStop Assurance PAC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.

About MasterBeef Group

MasterBeef Group is a full-service restaurant group in Hong Kong, specializing in Taiwanese hotpot and Taiwanese barbecue. The Company, through its Hong Kong operating subsidiaries, operates 12 restaurant outlets under the Master Beef and Anping Grill brands. For more information, please visit the Company’s website: masterbeefgroup.com.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the “Risk Factors” section of the Registration Statement filed with the Securities and Exchange Commission (the “SEC”). Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. 

For more information, please contact: MasterBeef Group Email: [email protected]

Contact:

Ka Chun Lam, Chief Executive Officer
Email address: [email protected]
Phone number: +852 3953 9388

Austin, Texas, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Digital Brands Group, Inc. (NASDAQ:DBGI) (the “Company,” “Digital Brands Group” or “DBG”) today announced that it has signed Herschel Supply Co., the globally recognized accessories brand, as a partner for AI-powered brand protection, through its collaboration with SECUR3D Inc.

As part of the initiative, Herschel Supply Co. is deploying SECUR3D’s AssetSafe™ platform, an AI-driven solution designed to identify, monitor, and address unauthorized use of brand assets across online marketplaces, social platforms, and digital channels. The effort is intended to help detect counterfeit goods, protect trademarks and product designs, and reinforce consumer trust across Herschel’s global eCommerce presence.

“Herschel is one of the most recognizable lifestyle brands in the world, and protecting brand integrity at scale has become essential in today’s digital economy,” said Hil Davis, Chief Executive Officer of Digital Brands Group. “This collaboration represents the first of many large consumer brands we expect to bring onto our AI-powered brand protection initiative as we expand partnerships across the global ecommerce landscape.”

The partnership reflects Digital Brands Group’s broader strategy of building a suite of technology-enabled solutions designed to support brand growth, integrity, and trust across its portfolio and partner ecosystem. By working with specialized providers like SECUR3D, the Company is creating an expanding ecosystem of brands leveraging AI-driven tools to address counterfeiting, unauthorized listings, and digital IP misuse at scale.

About Herschel Supply Co.

Founded in 2009, Herschel Supply Co. is a design-driven global accessories brand based in Vancouver, Canada. Herschel products are sold in more than 90 countries and carried by thousands of retailers worldwide, spanning backpacks, luggage, travel accessories, and apparel.

About SECUR3D

SECUR3D is an AI-powered brand and intellectual property protection company. Its flagship AssetSafe™ platform provides proactive detection, ongoing monitoring, and automated enforcement to help brands identify and address unauthorized use of IP across global ecommerce marketplaces and digital channels.

About Digital Brands Group

We offer a wide variety of apparel through numerous brands on a both direct-to-consumer and wholesale basis. We have created a business model derived from our founding as a digitally native-first vertical brand. We focus on owning the customer's "closet share" by leveraging their data and purchase history to create personalized targeted content and looks for that specific customer cohort.

Digital Brands Group, Inc. Company Contact
Hil Davis, CEO
Email: [email protected]
https://ir.digitalbrandsgroup.co

Forward-looking Statements

Certain statements included in this release are "forward-looking statements" within the meaning of the federal securities laws. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting DBG and therefore involve several risks and uncertainties. You can identify these statements by the fact that they use words such as “will,” “anticipate,” “estimate,” “expect,” “should,” and “may” and other words and terms of similar meaning or use of future dates, however, the absence of these words or similar expressions does not mean that a statement is not forward-looking. All statements regarding DBG’s plans, objectives, projections and expectations relating to DBG’s operations or financial performance, and assumptions related thereto are forward-looking statements. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. DBG undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Potential risks and uncertainties that could cause the actual results of operations or financial condition of DBG to differ materially from those expressed or implied by forward-looking statements include, but are not limited to: the Company’s ability to successfully integrate OPN to achieve the expected results; the level of consumer demand for apparel and accessories; disruption to DBGs distribution system; the financial strength of DBG’s customers; fluctuations in the price, availability and quality of raw materials and contracted products; disruption and volatility in the global capital and credit markets; DBG’s response to changing fashion trends, evolving consumer preferences and changing patterns of consumer behavior; intense competition from online retailers; manufacturing and product innovation; increasing pressure on margins; DBG’s ability to implement its business strategy; DBG’s ability to grow its wholesale and direct-to-consumer businesses; retail industry changes and challenges; DBG’s and its vendors’ ability to maintain the strength and security of information technology systems; the risk that DBG’s facilities and systems and those of our third-party service providers may be vulnerable to and unable to anticipate or detect data security breaches and data or financial loss; DBG’s ability to properly collect, use, manage and secure consumer and employee data; stability of DBG’s manufacturing facilities and foreign suppliers; continued use by DBG’s suppliers of ethical business practices; DBG’s ability to accurately forecast demand for products; continuity of members of DBG’s management; DBG’s ability to protect trademarks and other intellectual property rights; possible goodwill and other asset impairment; DBG’s ability to execute and integrate acquisitions; changes in tax laws and liabilities; legal, regulatory, political and economic risks; adverse or unexpected weather conditions; DBG's indebtedness and its ability to obtain financing on favorable terms, if needed, could prevent DBG from fulfilling its financial obligations; and climate change and increased focus on sustainability issues. More information on potential factors that could affect DBG’s financial results is included from time to time in DBG’s public reports filed with the U.S. Securities and Exchange Commission (the “SEC”), including DBG’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Forms 8-K, each filed or furnished with the SEC.

Shimmick continues to advance sustainable transportation and critical infrastructure projects in Southern CA

December 16, 2025 08:30 ET

 | Source:

Shimmick Corporation

IRVINE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Shimmick Corporation (Nasdaq: SHIM) ("Shimmick" or the "Company"), a national leader in complex infrastructure solutions, has been named the preferred bidder on two projects in the Los Angeles market, totaling approximately $81.5 million in new work. The projects span water and electrical infrastructure and reflect growing demand for Shimmick's integrated civil and electrical delivery capabilities.

"These projects reflect continued investment in essential water and electrical infrastructure that supports long-term resilience," said Ural Yal, Chief Executive Officer of Shimmick. "From advancing shore power to strengthening critical water reclamation facilities, our teams are partnering with public agencies to deliver solutions that improve sustainability and performance while benefiting the communities they serve."

Berths 49–51 Outer Harbor Cruise Terminal Development, $61.3 million, Los Angeles, CA

This project for the Port of Los Angeles (Port) includes significant electrical, structural, and civil improvements to support shore power — also known as Alternative Maritime Power (AMP) — and modern cruise terminal operations. Scope includes construction of a new Los Angeles Department of Water and Power (LADWP) 34.5-kV industrial station, installation of medium-voltage switchgear and shore power infrastructure, concrete wharf repairs, installation of a hybrid fender system, utility upgrades, and site improvements that enhance pedestrian and vehicular access, safety, and security. The project supports long-term sustainability objectives by strengthening aging marine infrastructure and enabling vessels to connect to shore power while docked, significantly reducing emissions.

Palmdale Water Reclamation Plant Influent Pump Station Modifications, $20.2 million, Palmdale, CA

This project for the Los Angeles County Sanitation District (LACSD) includes upgrades to influent pumping and electrical systems, construction of a new utility building, and associated civil improvements. The work will enhance operational reliability, improve system performance, and support long-term water reclamation operations serving the surrounding region.

Construction on both projects is expected to begin in 2026, following completion of final permitting and preconstruction activities.

About Shimmick

Shimmick Corporation (NASDAQ: SHIM) is an industry leader in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resilience, and sustainable transportation. We integrate technical excellence with collaborative project delivery methods to provide innovative, technology-driven infrastructure solutions that accelerate economic growth and empower communities nationwide. With a track record spanning over a century, Shimmick, headquartered in California, unites a deep engineering heritage with an entrepreneurial spirit to tackle today's most complex infrastructure challenges. For more information, visit www.shimmick.com.

Investor Relations:
[email protected]
1-949-704-2350

Media Contact:
Lee Ann Ballew
[email protected]

HomeETFs and Funds AnalysisETF Analysis

SummarySector value scores have deteriorated, but beverages and food remain notably undervalued versus 11-year baselines; tobacco is deeply overvalued with low quality.XLP has lagged the S&P 500 since 1999, offering lower risk but also inferior risk-adjusted performance.RSPS offers a more balanced approach for investors seeking diversification.Four stocks were cheaper than their peers in December. bgwalker/iStock Unreleased via Getty Images

This monthly article offers a top-down view of the consumer staples sector based on value, quality, and momentum metrics. It may also help analyze sector ETFs such as the State Street® Consumer Staples Select Sector SPDR® ETF (

Analyst’s Disclosure:I/we have a beneficial long position in the shares of KO, MO, PG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

December 16, 2025 08:33 ET

 | Source:

Loblaws Companies Limited

Not for distribution to U.S. News Wire Services or dissemination in the United States.

BRAMPTON, Ontario, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Loblaw Companies Limited (“Loblaw” or the “Company”) announced today that it has completed its previously announced issuance (the “Offering”), on a private placement basis to qualified accredited investors in certain Provinces of Canada, of $500 million aggregate principal amount of senior unsecured notes of the Company (the “Notes”). The Notes bear interest at a rate of 4.387% per annum and mature on June 16, 2035.

The Company intends to use the net proceeds of the Offering to repay outstanding indebtedness under the Company’s syndicated revolving credit facility and for general corporate purposes.

The Notes are unsecured obligations of the Company and rank equally with all existing and future unsecured and unsubordinated indebtedness of the Company.

Morningstar DBRS has provided the Notes with a credit rating of “BBB (high)” with a “Positive” trend and Standard and Poor’s Rating Services has provided the Notes with a credit rating of “BBB+”.

The Notes were sold on an agency basis by a syndicate of agents led by CIBC Capital Markets, RBC Capital Markets, TD Securities, BMO Capital Markets and Scotia Capital. The Notes have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the Notes in any jurisdiction where such offer, solicitation or sale would be unlawful.

About Loblaw Companies Limited

Loblaw is Canada’s food and pharmacy leader, and the nation’s largest retailer. Loblaw provides Canadians with grocery, pharmacy and health services, other health and beauty products, apparel, general merchandise, financial services and wireless mobile products and services. With more than 2,800 locations, Loblaw, its franchisees and Associate-owners employ more than 220,000 full- and part-time employees, making it one of Canada’s largest private sector employers.

Loblaw’s purpose — Live Life Well® — puts first the needs and well-being of Canadians who make one billion transactions annually in the Company’s stores. Loblaw is positioned to meet and exceed those needs in many ways: convenient locations; more than 1,100 grocery stores that span the value spectrum from discount to specialty; full-service pharmacies at nearly 1,400 Shoppers Drug Mart® and Pharmaprix® locations and in close to 500 grocery stores; PC Financial® services; affordable Joe Fresh® fashion and family apparel; and four of Canada’s top-consumer brands in Life Brand®, Farmer’s Market™, no name® and President’s Choice®. For more information, visit Loblaw’s website at www.loblaw.ca and Loblaw’s issuer profile at www.sedarplus.ca.

Forward-Looking Statements

This press release may contain forward-looking information within the meaning of applicable securities legislation, which reflects Loblaw's current expectations regarding future events, including the intended use of proceeds of the Offering. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Loblaw's control that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the factors discussed in Loblaw’s 2025 Third Quarter Report to Shareholders and current Annual Information Form. Loblaw does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. All forward-looking statements contained in this press release are made as of the date hereof and are qualified by these cautionary statements.

For further information please contact:
Roy MacDonald
Vice President, Investor Relations
[email protected]

December 16, 2025 07:22 ET

 | Source:

Gilat Satellite Networks Ltd.

PETAH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) (“Gilat” or the “Company”), a worldwide leader in satellite networking technology, solutions and services, announced today that, following the approval of its Board of Directors, it has received and accepted commitments from Israeli institutional and accredited investors (as defined under Israel’s Securities Law, 5728-1968) (the “Investors”), to participate in a private placement (the “Private Placement”) of Ordinary Shares of the Company (“Ordinary Shares”).

The Company is expected to issue and sell to the Investors an aggregate of 8,888,889 Ordinary Shares (the “Shares”), for a purchase price of US$11.25 per Share, which represents an approximately 7.9% discount to the 10-day Volume Weighted Average Price (VWAP)1. The newly issued Shares are expected to represent approximately 12.15% of the Company’s issued and outstanding Ordinary Shares after the consummation of such sale. The closing of the transaction is subject to customary closing conditions and is expected to be completed in December 2025.

The Company expects to receive net proceeds from the sale of the Shares, after deducting offering expenses, of approximately US$98.8 million. The Company intends to use such proceeds for general corporate purposes, including potential strategic acquisitions.

The Private Placement is being made in Israel only and not to U.S. persons, as defined in Rule 902 of the U.S. Securities Act of 1933, as amended (the “Securities Act”), pursuant to a registration exemption afforded by Regulation S promulgated under the Securities Act, and the Shares will be subject to certain transfer restrictions. The Shares will not be registered under the Securities Act and will not be offered or sold in the United States without registration or applicable exemption from the registration requirements according to the Securities Act.

This press release does not constitute an offer to sell or the solicitation of an offer to buy or subscribe for any securities or a solicitation of any vote or approval nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation, sale, issuance or transfer would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

Legal Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements in this press release include, but are not limited to, statements related to our expectations regarding the issuance and sale of the shares, the closing date of the transaction, and the Company’s intended use of the proceeds from the sale of the Shares. Our expectations and beliefs regarding these matters may not materialize, and actual results or events in the future are subject to risks and uncertainties that could cause actual results or events to differ materially from those projected, including, without limitation, as a result of the war and hostilities between Israel and Hamas, Hezbollah, Iran and the Houthi movement. The forward-looking statements contained in this press release are subject to other risks and uncertainties, including those more fully described in our filings with the Securities and Exchange Commission, including our Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 27, 2025. The forward-looking statements in this press release are based on information available to the Company as of the date hereof, and the Company disclaims any obligation to update any forward-looking statements, except as required by law.

About Gilat

Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is a leading global provider of satellite-based broadband communications. With over 35 years of experience, we develop and deliver deep technology solutions for satellite, ground, and new space connectivity, offering next-generation solutions and services for critical connectivity across commercial and defense applications. We believe in the right of all people to be connected and are united in our resolution to provide communication solutions to all reaches of the world.

Together with our wholly owned subsidiaries, Gilat Wavestream, Gilat DataPath, and Gilat Stellar Blu, we offer integrated, high-value solutions supporting multi-orbit constellations, Very High Throughput Satellites (VHTS), and Software-Defined Satellites (SDS) via our Commercial and Defense Divisions. Our comprehensive portfolio is comprised of a cloud-based platform and modems, high-performance satellite terminals, advanced Satellite On-the-Move (SOTM) antennas and ESAs, highly efficient, high-power Solid State Power Amplifiers (SSPA) and Block Upconverters (BUC) and includes integrated ground systems for commercial and defense markets, field services, network management software, and cybersecurity services.

Gilat’s products and tailored solutions support multiple applications including government and defense, IFC and mobility, broadband access, cellular backhaul, enterprise, aerospace, broadcast, and critical infrastructure clients all while meeting the most stringent service level requirements. For more information, please visit: http://www.gilat.com

Contact:

Gilat Satellite Networks

Hagay Katz, Chief Product and Marketing Officer

[email protected]

Alliance Advisors:

[email protected]
Phone: +1 212 838 3777

1 Calculated based upon the closing share price on Nasdaq on the 10 consecutive trading days ending on December 15, 2025.

Pfizer expects revenue and earnings to fall in 2026.

The technology sector has been a more than attractive buying opportunity after this year’s explosive run, and analysts believe the momentum is likely to continue next year. With that in mind, Finbold has come up with a list of the top three biggest tech stocks to buy in 2026.

1. Alphabet (GOOGL)
The first tech stock on the list is Alphabet (NASDAQ: GOOGL), so far the most impressive ‘Magnificent Seven’ stock this year, outperforming both its peers and the S&P 500 by a significant margin. 

At press time, GOOGL shares were trading at just above $308, up nearly 63% year-to-date.

GOOGL stock price YTD. Source: Finbold
Google’s parent company has found a lot of success in the artificial intelligence (AI) race thanks to its flagship Gemini models and custom chip, the Tensor Processing Unit (TPU), which has positioned the company as a serious competitor in the data center business.

So now, TPUs have been used internally or offered via Google Cloud as rented computing power, but considering how well they are performing, Alphabet is likely to forge some new partnerships around them.

Indeed, Meta (NASDAQ: META) is reportedly already looking to leverage the technology, and if Mark Zuckerberg breaks the ice, the move would unlock an entirely new revenue stream that markets have yet to fully price in.

2. Nvidia (NVDA)
While Google has been picking up the pace, Nvidia (NASDAQ: NVDA) still remains most closely associated with AI and related fields in the public consciousness, and rightfully so. Namely, the chipmaker has posted a 31.6% gain year-to-date, trading at around $176 at the time of writing.

NVDA stock price YTD. Source: Finbold
Nvidia’s strength lies mostly in the popularity of its GPUs, which are employed by sector leaders such as OpenAI, and whose general-purpose flexibility gives them a wide range of potential use cases. Most notably, of course, the chips are the data center bread and butter.

On December 15, the semiconductor giant also released a new line of open-source AI models, Nemotron 3, designed for building AI agents. In the press release, CEO Jensen Huang noted that access to innovation is the foundation of progress, adding that the new Nemotron family will help turn advanced artificial intelligence into an open platform and allow developers to scale more easily. 

If the new approach proves fruitful, Nvidia’s position as the go-to tech stock could solidify even further in 2026.

3. Tesla (TSLA)
While primarily an automaker, Tesla (NASDAQ: TSLA)can be rightfully called a tech stock, too, given its recent emphasis on robotics and artificial intelligence. At press time,TSLA shares were changing hands at almost $473, up 17% since the beginning of the year.

TSLA stock price YTD. Source: Finbold
CEO Elon Musk’s growing interest in automated driving and AI has gained a lot of analyst attention. For example, Wedbush’s Dan Ives has recently hinted at a potential $800 Tesla price target in 2026, arguing the car company’s market cap could double next year.

The positive investor sentiment is being bolstered by this month’s autonomous vehicle testing in Austin, Texas, where Tesla Model Y units are starting to operate without a safety driver this weekend. In the meantime, the management is focusing on bettering sales in Europe, introducing more affordable models in the hopes of removing some headwinds it was facing in the region.

If Musk’s new strategy pays out, Tesla’s reputation as a viable tech stock will certainly grow in the following months, potentially contributing to future gains.

Tech stocks to buy in 2026
In sum, the technology industry continues to offer investors compelling opportunities, with innovation in a variety of fields, including artificial intelligence, semiconductors, and automation.

Alphabet, Nvidia, and Tesla stand out as the top 3 big tech stocks to buy in 2026, each bringing its own unique strengths to the table that position them well for potential gains next year. 

While no investment is without risk, these three tech giants remain at the forefront of technological progress and could be worth considering for investors looking to capitalize on the current technological trends.

Featured image via Shutterstock

DALLAS--(BUSINESS WIRE)--Flowserve Corporation (NYSE:FLS) (“Flowserve” or the “Company”), a leading provider of flow control products and services for the global infrastructure markets, announced today that it has acquired U.K.-based Greenray Turbine Solutions, Ltd. (“Greenray”), a comprehensive provider of aftermarket products and services for industrial gas turbines. Through this acquisition, Flowserve gains access to deep product expertise and durable revenue for a large installed base of mi.

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) is pleased to announce updated and complete assay results from the Trapper Gold Target at its wholly owned Thorn Project in northwestern British Columbia. This release includes multi-element results for all remaining holes from the 2025 campaign, as well as updated intervals for previously reported drill holes where only gold was disclosed. A total of 6272m was drilled at the Trapper Target from 30 holes this season. The Trapper gold zone remains open for expansion.

Highlights

Gold and silver mineralization were intersected in drilling at the Trapper Gold Target, extending up to 1km away from the main mineralized zone, within the NW-SE trending gold-in-soil anomaly.Hole THN25-358 returned 3.00m of 4.27 g/t gold and 11.63 g/t silver from 51.70m depthHole THN25-352 returned 1.50m of 4.62 g/t gold and 5.06 g/t silver from 28.5m depthHole THN25-364 returned 1.20m of 11.45 g/t gold and 9.21 g/t silver from 119m depth Additional significant intervals in Table 1.

Holes with previously reported gold values now including silver values

Hole THN25-344 returned 38.50m of 4.07 g/t gold and 6.71 g/t silver from 191.00m depthIncluding 1.85m of 39.61g/t gold and 30.91 g/t silver from 220.00m depth Hole THN25-345 returned 22.15m of 4.44 g/t gold and 3.45 g/t silver from 203.85m depthIncluding 3.00m of 28.83 g/t gold and 14.18 g/t silver from 223.00m depth Hole THN25-361 returned 23.50m of 3.33 g/t gold and 3.36 g/t silver from 92.00m depthIncluding 0.50m of 112.00 g/t gold and 45.30 g/t silver from 112.00m depth Additional significant intervals in Table 2.

Chairman, CEO, Gary R. Thompson stated, “We are very pleased to deliver the multi-element assay results from the 2025 Trapper Gold Target campaign. These results not only confirm the continuity of high-grade gold mineralization but also demonstrate the presence of significant silver intervals across the target area. The updated data from previously reported drill holes, combined with new results from the remaining holes, further expand our understanding of the Trapper system and reinforce its potential for a large-scale mineralized system. We look forward to advancing exploration at Trapper and the broader Thorn Project as we continue to unlock value for our shareholders.”

Figure 1. Plan Map of all 2025 Drill Collars within the Trapper Target. Long section A-B on Figure 2.

Table 1. Select Assay Intervals for holes at the Trapper Target.

Hole IDFromToIntervalGoldSilvermetermetermeterg/tg/t      THN25-34939.2439.780.540.6813.20      THN25-3506.688.001.320.447.29      THN25-3529.5010.601.101.712.1828.5030.001.504.625.06      THN25-35381.5083.001.500.5211.75      THN25-355no significant intervals      THN25-357no significant intervals      THN25-35851.7054.703.004.2711.63129.00130.501.503.3214.55      THN25-3593.005.602.601.698.1634.0038.504.501.854.6779.5082.503.001.8410.74      THN25-364119.00120.201.2011.459.21THN25-364151.40153.001.605.8323.97including151.40152.000.6012.1537.80
Assay values are weighted averages. Reported intervals are drilling length, and the true width of the mineralized intervals has not yet been determined.

Table 2. Select Assay Intervals for updated silver values at Trapper Target.

Hole IDFromToIntervalGold*Silvermetermetermeterg/tg/tTHN25-33723.5033.5010.003.068.75including27.1033.506.404.618.74THN25-33795.0099.004.001.446.85      THN25-33916.0031.0015.002.269.15including22.0025.003.004.6819.24THN25-33953.5058.505.002.604.51including57.0058.501.506.708.94THN25-33976.0077.501.507.0627.95THN25-339242.50244.001.502.618.06THN25-339278.50280.001.502.624.46THN25-339288.05291.002.951.8310.28      THN25-342210.00214.004.002.223.56      THN25-344191.00229.5038.504.076.71including220.00221.851.8539.6130.91THN25-344281.65288.006.351.813.77      THN25-345203.85226.0022.154.443.45including223.00226.003.0028.8314.18      THN25-36192.00115.5023.503.333.36including92.5094.001.504.167.21including112.00112.500.50112.0045.30      THN25-36360.0072.5012.501.994.36including68.5072.504.004.324.45THN25-363116.00141.5025.503.167.81including122.00124.652.657.3819.93including127.15127.650.5010.8028.30including133.15141.508.354.637.49
*Gold values previously reported.

Assay values are weighted averages. Reported intervals are drilling length, and the true width of the mineralized intervals has not yet been determined.

Discussion – Trapper Gold Target

The 2025 campaign focused on expanding the known gold and silver mineralization within the central mineralized area and testing the continuity of mineralization, as observed in the 4 km-long, northwest-southeast-trending gold-in-soils anomaly (Figure 1). This strategic approach aimed to build on previous successes and further delineate the extent of high-grade gold zones at the Trapper Target (Figure 2).

The 2025 drill program successfully continued to demonstrate the significant gold and silver endowment of the Trapper Target. This year, a total of 6,272 meters were drilled across 30 holes, with the best intercepts represented by hole THN25-344, which returned 38.50 meters of 4.07 g/t gold and 6.71 g/t silver from 191.00 meters, and hole THN25-345, which returned 22.15 meters of 4.44 g/t gold and 3.45 g/t silver from 203.85 meters. These results reinforce the continuity and scale of high-grade mineralization at Trapper, supporting its potential for a large-scale mineralized system.

Gold mineralization at Trapper is structurally controlled, trending northwest-southeast and dipping moderately to the north in the main drilling area. Mineralization appears to favour the contact between the Cretaceous (85.2 ± 1.2 Ma) quartz diorite and Triassic lapilli tuffs, with broad gold intervals largely hosted along these faulted contacts. The gold is associated with silver and base metal veins containing pyrite, galena, sphalerite, and locally chalcopyrite and bornite.

The geochemical footprint for the Trapper Gold Target was expanded in 2021 to 4 km by 1.5 km, with a gold-in-soil signature strongly correlated to zinc and lead. Visible gold has been identified in both drill core and surface outcrops (Figure 3). Gold occurs in several environments: within base metal veins (sphalerite-galena-pyrite-chalcopyrite), quartz-stockwork, sulphosalt-pyrite veinlets, and, more rarely, disseminated in the diorite and feldspar porphyries.

Through a combination of oriented core drilling, surface mapping, geochemistry, and geophysics, Brixton aims to improve the predictability of gold-bearing zones and expand the mineralized footprint. The Trapper Target remains royalty-free, and ongoing work will focus on identifying new zones of gold-bearing mineralization under the footprint of the extensive geochemical anomaly. The zone remains open for expansion, and future exploration will target both known and newly interpreted structural corridors.

Figure 2. Trapper Long Section showing extension of mineralization within the central zone with selected 2025 drillholes and historic results. Direction of section as noted in Figure 1.

Figure 3. HQ drill core photograph of Hole THN25-361 at 112.2 meters showing a fleck of gold in a brecciated quartz-ankerite-pyrite-sphalerite vein hosted in sericite-chlorite altered Stuhini volcaniclastics.

Figure 4. HQ drill core photograph of hole THN25-364 at 152 meters showing pyrite-sphalerite-galena-chalcopyrite vein hosted in sericite-chlorite-calcite altered Stuhini volcaniclastics.

Table 3. Collar Location for Reported Drillholes.

Hole IDEasting (m)Northing (m)Elevation (m)AzimuthDipDepth (m)THN25-3376304516485368126510-45389THN25-3396304516485368126530-45346THN25-342630227648548313358-50270THN25-34563022764854831335355-45262THN25-3496315966484722134210-50117THN25-35063159664847221342350-50143THN25-3526315736484714133610-50215THN25-3536315366484708132510-50164THN25-3556309746484790119820-70139THN25-35763097464847901198340-70134THN25-3586305196485400122620-65175THN25-35963051964854001226340-65182THN25-36163037464855981276215-45164THN25-36363037464855981276215-80188THN25-3646303746485598127635-80232
Quality Assurance & Quality Control

Quality assurance and quality control protocols for drill core sampling were developed by Brixton. Core samples were mostly taken at 1.5m intervals. High-grade intervals were taken at 0.5m. Blank, duplicate (lab pulp) and certified reference materials were inserted at a combined rate of up to 15%. Core samples were cut in half, bagged, zip-tied, and sent directly to the ALS Minerals preparation facility in Whitehorse, Yukon, or Langley, British Columbia, depending on available lab capacity. ALS Minerals Laboratories is registered to ISO 9001:2008 and ISO 17025 accreditations for laboratory procedures. Samples were analyzed at ALS Laboratory Facilities in North Vancouver, British Columbia, for gold by fire assay with an atomic absorption finish, whereas Ag, Pb, Cu and Zn and 48 additional elements were analyzed using four acid digestion with an ICP-MS finish. Overlimits for gold were analyzed using fire assay and gravimetric finish. The standards, certified reference materials, were acquired from CDN Resource Laboratories Ltd. of Langley, British Columbia, and the standards inserted varied depending on the type and abundance of mineralization visually observed in the primary sample. Blank material used consisted of non-mineralized siliceous landscaping rock. A copy of the QAQC protocols can be viewed at the Company’s website.

Qualified Person (QP)

Mr. Gary R. Thompson, P.Geo., is a Director, Chairman, CEO and President for the Company who is a Qualified Person as defined by National Instrument 43-101. Mr. Thompson has verified the referenced data and analytical results disclosed in this press release and has approved the technical information presented herein.

About Brixton Metals Corporation

Brixton Metals is a Canadian exploration company focused on the advancement of its mining projects. Brixton wholly owns four exploration projects: Brixton’s flagship Thorn copper-gold-silver-molybdenum Project, the Hog Heaven copper-silver-gold Project in NW Montana, USA, which is optioned to Ivanhoe Electric Inc., the Langis-HudBay silver-cobalt-nickel Project in Ontario and the Atlin Goldfields Project located in northwest BC, which is optioned to Eldorado Gold Corporation. Brixton Metals Corporation shares trade on the TSX-V under the ticker symbol BBB, and on the OTCQB under the ticker symbol BBBXF. For more information about Brixton, please visit our website at www.brixtonmetals.com.

On Behalf of the Board of Directors

Mr. Gary R. Thompson, Chairman and CEO
[email protected]

For Investor Relations inquiries please contact: Mr. Michael Rapsch, Vice President Investor Relations. email: [email protected] or call Tel: 604-630-9707
Follow us on:
LinkedIn | Twitter/X | Facebook | Instagram

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, including statements that address potential quantity and/or grade of minerals, potential size and expansion of a mineralized zone, proposed timing of exploration and development plans, or other similar expressions. All statements, other than statements of historical fact included herein including, without limitation, statements regarding the use of proceeds. By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following risks: the need for additional financing; operational risks associated with mineral exploration; fluctuations in commodity prices; title matters; and the additional risks identified in the annual information form of the Company or other reports and filings with the TSXV and applicable Canadian securities regulators. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made and the Company undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements.

Photos accompanying this announcement are available at: 

https://brixtonmetals.com/wp-content/uploads/2025/12/Figure-1-NR-16Dec2025-scaled.png

https://brixtonmetals.com/wp-content/uploads/2025/12/Figure-2-NR-16Dec2025-scaled.png

https://brixtonmetals.com/wp-content/uploads/2025/12/Figure-3-NR-16-Dec2025wb-scaled.png

https://brixtonmetals.com/wp-content/uploads/2025/12/Figure-4-NR-16Dec2025wb.jpg

NORTH YORK, ON / ACCESS Newswire / December 16, 2025 / ZTEST Electronics Inc. ("ZTEST" or the "Company") (CSE:ZTE)(OTCID:ZTSTF) announces that it has granted 900,000 stock options to the Directors, Officers and Employees of the Company, exercisable at $0.28 per share for 5 years vesting as to 50% after 6 months and the balance after 1 year.

About ZTEST Electronics Inc.

ZTEST Electronics Inc., through its wholly owned subsidiary Permatech Electronics Corporation ("Permatech"), offers Electronic Manufacturing Services (EMS) to a wide range of customers. Permatech's offering includes Printed Circuit Board (PCB) Assembly, Materials Management and Testing services. Permatech operates from an ISO 9001:2015 certified facility in North York, Ontario, Canada. Permatech is a contract assembler of complex circuit boards, serving customers in the Medical, Power, Computer, Telecommunications, Wireless, Industrial, Trucking, Wearables and Consumer Electronics markets. It specializes in servicing customers who are looking for high yield and require high quality and rapid-turnaround on low and mid-volume production of high complexity products.

For more information contact: Steve Smith, CEO (604) 837-3751 email: [email protected]

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING STATEMENTS: This press release contains forward looking statements, which relate to future events or future performance and reflect management's current expectations and assumptions. Such forward looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward-looking statements are neither promises nor guarantees and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances. All of the forward-looking statements made in this press release are qualified by these cautionary statements and by those made in our filings with SEDAR+ in Canada (available at www.sedarplus.com).

SOURCE: ZTEST Electronics Inc.

HomeETFs and Funds AnalysisETF Analysis

SummaryWater utilities are undervalued by 18% versus 11-year averages, while electricity/multi-utilities and gas utilities are slightly overvalued.iShares U.S. Utilities ETF offers similar long-term risk/return as XLU, despite higher fees and broader sector exposure.XLU is preferable for trading and tactical allocation due to higher liquidity, while RSPU offers more balanced company exposure.10 utility stocks were cheaper than their peers in December. mgstudyo/iStock via Getty Images

This monthly article offers a top-down view of the utilities sector based on value, quality, and momentum metrics. It may also help analyze sector ETFs such as Utilities Select Sector SPDR Fund ETF (XLU

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES    Vancouver, BC, December 16, 2025 – TheNewswire – Silver North Resources Ltd. (TSX-V: SNAG, OTCQB: TARSF) “ Silver North ” or the “ Company ”) is pleased to announce an increase in the non-brokered private placement (the “ Offering ”) which is now for aggregate gross proceeds of up to $2,250,500 from the sale of 6,430,000 million flow-through shares of the Company (the “ FT Shares ”) to be sold at a price of $0.35 per FT Share. Each FT Share will be comprised of one common share that will qualify as a “flow-through share” within the meaning of subsection 66(15) of the Income Tax Act (Canada) (the “ Tax Act ”).

Industry Leaders Point to Challenging Political and Economic Environment

Key Legislation Expected to Impact Supply Chain and Drug Costs

Recent M&A Momentum Offset by Challenging Fundraising Environment

Artificial Intelligence (AI) Seen as Key Investment Area

WASHINGTON, Dec. 16, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced findings from its fifth annual U.S. Healthcare & Life Sciences Industry Outlook 2026, which revealed that leaders are less optimistic about the state of the industry, down 9% from last year’s survey.

The survey indicates that while optimism persists in some areas, industry leaders are navigating significant challenges within the capital markets, evolving political and regulatory landscapes, and have ongoing cybersecurity concerns.

“As we look towards 2026, life sciences companies face a complex landscape of shifting financial and regulatory factors, which demand strategic agility,” said Robert Stanislaro, Head of the Healthcare & Life Sciences’ Corporate Reputation offering within FTI Consulting’s Strategic Communications segment. “Organizations that prioritize scenario planning and incorporate those insights, as well as leverage AI to drive efficiencies, into future business plans will be best positioned to navigate the challenges and opportunities ahead.”

Policy and Regulatory Challenges
A year into President Trump’s second presidency, life sciences leaders remain divided (51% positive versus 49% negative) about his impact on the industry to-date. Notably, respondents view Secretary of Health and Human Services Robert F. Kennedy Jr. and Food and Drug Administration Commissioner Dr. Marty Markay somewhat more favorably, with 51% and 53% positive ratings. Policy concerns are also prominent, with 64% believing the One Big Beautiful Bill Act will increase out-of-pocket costs for patients, and 56% anticipating that President Trump’s Most Favored Nation policy will increase supply chain disruptions.

Artificial Intelligence Development & Usage
Despite economic headwinds, 59% of respondents plan to allocate additional budget to AI and large-language models in 2026. Organizations are expecting to implement AI across multiple functions, including for the development of internal content (41%), internal operations (38%), financial analysis (37%), patient support/hub services (34%), and personalized marketing (31%). In communications specifically, leaders see AI offering the greatest opportunities in social and digital communications (63%), media engagement (48%), issues management (48%), thought leadership (47%), and earnings/investor communications (45%).

Cybersecurity Concerns
The survey also reveals concerning trends in cybersecurity readiness. Nearly half (47%) of respondents perceive their organizations as vulnerable to cyber incidents. However, only 60% of respondents have a crisis communications plan in place, down from 68% in 2025, and participation in simulation exercises has dropped to 47% from 53% in 2025.

Transactions & Capital Markets Activity
While 65% of respondents expect M&A activity to be higher in 2026, only 54% of leaders are optimistic about increased IPO activity, representing a 7% drop from 2025. The fundraising environment is also predicted to be increasingly challenging, with only 28% of respondents believing that it will be easier to raise capital in 2026.

“Our findings reveal a life sciences industry that remains resilient but increasingly cautious as we enter 2026,” said Lauren Crawford Shaver, Americas Head of Healthcare & Life Sciences within FTI Consulting’s Strategic Communications segment. “While the majority of leaders maintain a sense of optimism, we're seeing notable shifts in sentiment around capital access, the political and regulatory climate, and desire to invest in new innovative technology such as AI.”

The full survey report is available here.

About the Survey
This research was conducted online by FTI Consulting’s Strategic Communications segment between September 10 and September 26, 2025, with 300 decision-makers in corporate communications, investor relations, public affairs, business development and marketing roles for healthcare and life sciences companies in the United States. Fifty-one percent of respondents represent large companies (with more than 250 employees), and roughly one quarter (28%) represent publicly listed companies with a weighted average $5 billion market cap.

About FTI Consulting  
FTI Consulting, Inc. is a leading global expert firm for organizations facing crisis and transformation, with more than 8,100 employees located in 32 countries and territories as of September 30, 2025. In certain jurisdictions, FTI Consulting’s services are provided through distinct legal entities that are separately capitalized and independently managed. The Company generated $3.70 billion in revenues during fiscal year 2024. More information can be found at www.fticonsulting.com.

FTI Consulting, Inc.
555 12th Street NW
Washington, DC 20004
+1.202.312.9100

Investor Contact:
Mollie Hawkes
+1.617.747.1791
[email protected]

Media Contact:
Nick Emmons
+1.617.510.1676
[email protected]